Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
editorial
. 1978 Jul 29;2(6133):308.

Lead and motor neurone disease.

PMCID: PMC1606435  PMID: 687892

Full text

PDF

Page 308

308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brain L., Croft P. B., Wilkinson M. Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease). Brain. 1965 Sep;88(3):479–500. doi: 10.1093/brain/88.3.479. [DOI] [PubMed] [Google Scholar]
  2. Broadwell R. D., Brightman M. W. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol. 1976 Apr 1;166(3):257–283. doi: 10.1002/cne.901660302. [DOI] [PubMed] [Google Scholar]
  3. Campbell A. M., Williams E. R., Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):877–885. doi: 10.1136/jnnp.33.6.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conradi S., Ronnevi L. O., Vesterberg O. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis. J Neurol Sci. 1976 Oct;29(2-4):259–265. doi: 10.1016/0022-510x(76)90175-1. [DOI] [PubMed] [Google Scholar]
  5. Conradi S., Ronnevi L. O., Vesterberg O. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry. J Neurol Neurosurg Psychiatry. 1978 May;41(5):389–393. doi: 10.1136/jnnp.41.5.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cremer N. E., Oshiro L. S., Norris F. H., Jr, Lennette E. H. Cultures of tissues from patients with amyotrophic lateral sclerosis. Arch Neurol. 1973 Nov;29(5):331–333. doi: 10.1001/archneur.1973.00490290071009. [DOI] [PubMed] [Google Scholar]
  7. Gustafson A., Störtebecker P. Vascular and metabolic studies of amyotrophic lateral sclerosis. II. Lipid and carbohydrate metabolism. Neurology. 1972 May;22(5):528–536. doi: 10.1212/wnl.22.5.528. [DOI] [PubMed] [Google Scholar]
  8. Hallen O., Brusis T., Pfisterer H. Die Myatrophia spinalis postpoliomyelitica chronica. Ein Beitrag zum Problem der sog. Poliomyelitis anterior chronica. Dtsch Z Nervenheilkd. 1969;195(4):333–343. [PubMed] [Google Scholar]
  9. Hirano A., Kurland L. T., Sayre G. P. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol. 1967 Mar;16(3):232–243. doi: 10.1001/archneur.1967.00470210008002. [DOI] [PubMed] [Google Scholar]
  10. IONASESCU V., LUCA N. STUDIES ON CARBOHYDRATE METABOLISM IN AMYOTROPHIC LATERAL SCLEROSIS AND HEREDITARY PROXIMAL SPINAL MUSCULAR ATROPHY. Acta Neurol Scand. 1964;40:47–57. doi: 10.1111/j.1600-0404.1964.tb04265.x. [DOI] [PubMed] [Google Scholar]
  11. KURLAND L. T. Epidemiologic investigations of amyotrophic lateral sclerosis. III. A genetic interpretation of incidence and geographic distribution. Proc Staff Meet Mayo Clin. 1957 Aug 21;32(17):449–462. [PubMed] [Google Scholar]
  12. KURLAND L. T., MULDER D. W. Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations. Neurology. 1954 May;4(5):355–378. doi: 10.1212/wnl.4.5.355. [DOI] [PubMed] [Google Scholar]
  13. Kurland L. T. An appraisal of the neurotoxicity of cycad and the etiology of amyotrophic lateral sclerosis on Guam. Fed Proc. 1972 Sep-Oct;31(5):1540–1542. [PubMed] [Google Scholar]
  14. Reed D. M., Brody J. A., Holden E. M. Predicting the duration of Guam amyotrophic lateral sclerosis. Neurology. 1975 Mar;25(3):277–280. doi: 10.1212/wnl.25.3.277. [DOI] [PubMed] [Google Scholar]
  15. Savolainen H., Palo J. Amyotrophic lateral sclerosis. Proteins of neuronal cell membranes, axons and myelin of the precentral gyrus and other cortical areas. Brain. 1973 Sep;96(3):537–546. doi: 10.1093/brain/96.3.537. [DOI] [PubMed] [Google Scholar]
  16. Störtebecker P., Nordström G., de Pestény M. P., Seeman T., Björkerud S. Vascular and metabolic studies of amyotrophic lateral sclerosis. I. Angiopathy in biopsy specimens of peripheral arteries. Neurology. 1970 Dec;20(12):1157–1160. doi: 10.1212/wnl.20.12.1157. [DOI] [PubMed] [Google Scholar]
  17. Urbánek K., Jansa P. Amyotrophic lateral sclerosis. Abnormal cellular inflammatory response. Arch Neurol. 1974 Feb;30(2):186–187. doi: 10.1001/archneur.1974.00490320074013. [DOI] [PubMed] [Google Scholar]
  18. Yase Y. The pathogenesis of amyotrophic lateral sclerosis. Lancet. 1972 Aug 12;2(7772):292–296. doi: 10.1016/s0140-6736(72)92903-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES